uniQure N.V. (QURE) Financials
QURE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 831.7 million | 624.0 million |
2023-09-30 | 871.6 million | 602.8 million |
2023-06-30 | 942.8 million | 589.4 million |
2023-03-31 | 631.0 million | 218.2 million |
QURE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -51.6 million | 7.0 million |
2023-09-30 | 37.2 million | 11.1 million |
2023-06-30 | -58.1 million | 8.9 million |
2023-03-31 | -80.6 million | 8.1 million |
QURE Net Income
No data available :(
QURE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 617.9 million | - | 36.7 million |
2023-09-30 | 658.9 million | - | 36.9 million |
2023-06-30 | 628.6 million | - | 38.0 million |
2023-03-31 | 315.3 million | - | 38.7 million |
QURE Shares Outstanding
QURE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.0 million | 42.6 million | 17.5 million | - |
2023-09-30 | 1.7 million | 65.4 million | 18.1 million | - |
2023-06-30 | 1.1 million | 46.0 million | 21.4 million | - |
2023-03-31 | 2.3 million | 60.8 million | 18.1 million | - |
QURE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 6.7 million | 8.8 million |
2023-09-30 | 1.4 million | 1.0 million |
2023-06-30 | 2.4 million | 1.4 million |
2023-03-31 | 5.3 million | 2.4 million |
QURE
Price: $4.53
52 week price:
Earnings Per Share: -6.47 USD
P/E Ratio: -1.11
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 380100
Ebitda: -8.2 millionMarket Capitalization: 228.7 million